henhaobio
Sign in

bioRxivImmunologyPreprint

LCK deficiency in CD8 T cells leads to reduced proliferation and increased effector T-cell formation in mice

Valeria UleriiD, Vojtech Racek, Marta Popovic, Anna Morales MendeziD, Veronika NiederlováiD, Arina AndreyevaiD, Juraj MichalikiD, Nadine M. WoessneriD, Michaela KrupkováiD, Radislav SedláčekiD, Susana MinguetiD, Ondřej ŠtěpánekiD

PDFDOI

Abstract

LCK is an SRC-family kinase that mediates the initial steps in T-cell antigen receptor signaling and governs positive and negative selection during thymocyte development. While its developmental role is well established, its functions in peripheral T-cell responses remain poorly defined. Here, we investigated the responses of wild-type and LCK-deficient TCR-transgenic OT-I T cells across two infection models and an autoimmune diabetes model. LCK-deficient T cells exhibited reduced antigen-induced proliferation but, paradoxically, displayed enhanced effector differentiation in vivo. This phenotype likely reflects dysregulation of specific TCR signaling pathways, as LCK was more critical for ERK and NFAT activation than for NF{kappa}B, AP-1, or AKT/mTOR signaling. T cells deficient in a related kinase FYN also showed a slight increase in effector cell formation, suggesting that effector differentiation is regulated by their combined activity rather than distinct non-redundant roles. Our results reveal that LCK has two intrinsic roles in T-cell responses - promoting proliferation while restraining effector differentiation. These findings provide new insight into the molecular mechanisms of T-cell activation in vivo with implications for understanding the pathophysiology of LCK deficiency in humans and optimizing adoptive T-cell therapies.

Citations
2

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.